Knockdown of MAYA in breast cancer cells with bone tropism (BoM-1833 cells) counteracts connective growth factor (CTGF) secretion and cancer cell-induced osteoclast differentiation and, consequently, limits the potential for osteolytic bone metastasis. This evidence concerns the gene MNX1-AS1 and breast carcinoma.